pathway_id,pathway_term,pathway_source,proteins
h_flumazenilPathway,"Cardiac Protection Against ROS ",BioCarta,GABRA5;GPX1
h_gabaPathway,"Gamma-aminobutyric Acid Receptor Life Cycle",BioCarta,GABRA5;NSF;GPHN;GABARAP
hsa04080,"Neuroactive ligand-receptor interaction",KEGG,CGA;HRH3;CHRM2;CHRM3;CHRNA5;CHRNA7;CHRNB1;ADCYAP1R1;CNR1;ADORA1;ADORA2B;ADRA1D;ADRA1B;ADRA1A;ADRA2B;ADRB1;ADRB2;ADRB3;DRD2;AGTR1;AGTR2;S1PR1;S1PR3;EDNRA;F2;F2R;F2RL1;FPR1;FPR2;FSHB;FSHR;GABBR1;GABRA5;GH1;GHR;GHSR;GLRB;GNRHR;NPBWR1;P2RY8;GRIA4;GRIN2A;NR3C1;GRM3;GRM6;GRM8;HRH1;HTR2B;HTR2C;HTR7;LEP;LEPR;LHB;LHCGR;MC2R;MC4R;MTNR1A;MTNR1B;NPY1R;NPY2R;NPY5R;OPRL1;OXTR;P2RX4;PLG;AVPR2;PRL;PRLR;PARD3;PRSS1;PRSS3;PTAFR;PTGDR;PTGER2;PTGER3;PTGER4;PTGFR;PTH2R;SSTR1;SSTR5;TSPO;THRA;C5AR1;TRPV1;KISS1R;CCKBR;GABBR2;P2RY14
hsa04723,"Retrograde endocannabinoid signaling",KEGG,ADCY3;ADCY7;MGLL;ADCY9;CNR1;MAPK14;DAGLB;NAPEPLD;PLCB1;GABRA5;GNAI1;GNAI2;GNAI3;GNAQ;GNB1;GNB2;GNB3;GNG4;GNG5;GNG7;GNG11;GRIA4;ITPR1;ITPR2;ITPR3;PRKACA;PRKCA;PRKCB;MAPK1;MAPK3;MAPK8;MAPK9;MAPK13;ABHD6;PTGS2;CACNA1C
hsa04727,"GABAergic synapse",KEGG,GPHN;ADCY3;ADCY7;GABARAP;GABARAPL2;ADCY9;ABAT;GABARAPL1;GABBR1;GABRA5;GLS;GNAI1;GNAI2;GNAI3;GNB1;GNB2;GNB3;GNG4;GNG5;GNG7;GNG11;NSF;PLCL1;PRKACA;PRKCA;PRKCB;SLC6A1;TRAK2;CACNA1C;SLC38A1;SLC38A5;GABBR2
hsa04742,"Taste transduction",KEGG,CHRM3;GABBR1;GABRA5;GNB3;ITPR3;ASIC2;PRKACA;SCN9A;SCNN1A;SCNN1G;CACNA1C;GABBR2
hsa05032,"Morphine addiction",KEGG,ADCY3;ADCY7;ADCY9;ADORA1;ADRBK2;GABBR1;GABRA5;PDE7B;GNAI1;GNAI2;GNAI3;GNAS;GNB1;GNB2;GNB3;GNG4;GNG5;GNG7;GNG11;GRK5;GRK6;PDE3A;PDE3B;PDE4C;PDE4D;PDE7A;PDE8A;PRKACA;PRKCA;PRKCB;PDE8B;GABBR2
hsa05033,"Nicotine addiction",KEGG,CHRNA7;GABRA5;GRIA4;GRIN2A